ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $36,000 | -30.8% | 914 | +0.9% | 0.01% | -25.0% |
Q2 2015 | $52,000 | -1.9% | 906 | +10.4% | 0.01% | 0.0% |
Q1 2015 | $53,000 | +12.8% | 821 | +7.7% | 0.01% | +14.3% |
Q4 2014 | $47,000 | +67.9% | 762 | +3.8% | 0.01% | +75.0% |
Q3 2014 | $28,000 | +33.3% | 734 | +6.8% | 0.00% | +33.3% |
Q2 2014 | $21,000 | -4.5% | 687 | +19.9% | 0.00% | 0.0% |
Q1 2014 | $22,000 | -15.4% | 573 | 0.0% | 0.00% | -25.0% |
Q4 2013 | $26,000 | +1200.0% | 573 | +839.3% | 0.00% | – |
Q3 2013 | $2,000 | – | 61 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |